Trials / Conditions / High-grade Squamous Intraepithelial Lesion
High-grade Squamous Intraepithelial Lesion
5 registered clinical trials studyying High-grade Squamous Intraepithelial Lesion.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions NCT03197025 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin L NCT02059499 | AIDS Malignancy Consortium | Phase 3 |
| Completed | Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions NCT02135419 | AIDS Malignancy Consortium | Phase 3 |
| Completed | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells NCT00091130 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix NCT00072540 | SWOG Cancer Research Network | Phase 2 |